Internal Medicine, Medical Oncology · New Port Richey, FL
NPI
1669432290
Since 2006
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
0
Medicare group memberships
Hospitals
1
Hospital affiliations
5125 Westshore Dr
New Port Richey, FL, 34652
Phone (727) 271-4009
Medicare paid, 2024
$2.3M
117,091 services
Medicare patients, 2024
637
Average age 76
Drug cost, 2024
$2.0M
1,046 prescriptions
Company payments, 2025
$2,767
From 40 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Gail L Wright was code Q0138 (injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)), 12,240 times for 17 patients. In total Gail L Wright billed 117,091 services in 139 codes, and Medicare paid $2.3M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-04-27.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | Office | 12,240 | 17 | $0.28 | $3,392 |
| J9271 Injection, pembrolizumab, 1 mg | Office | 8,800 | 12 | $44.46 | $391K |
| J0897 Injection, denosumab, 1 mg | Office | 6,600 | 58 | $20.12 | $133K |
| J0885 Injection, epoetin alfa, (for non-esrd use), 1000 units | Office | 1,980 | 20 | $6.37 | $13K |
| 85025 Blood Count | Office | 1,702 | 484 | $7.60 | $13K |
| J1437 Injection, ferric derisomaltose, 10 mg | Office | 1,600 | 15 | $16.00 | $26K |
| 36415 Venipuncture Blood Collection | Office | 1,445 | 466 | $8.64 | $12K |
| 99214 Office E&M - Established | Office | 1,189 | 384 | $93.06 | $111K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 1,110 | 19 | $0.09 | $101 |
| 96372 Injection Administration | Office | 998 | 195 | $10.23 | $10K |
| J2405 Injection, ondansetron hydrochloride, per 1 mg | Office | 912 | 18 | $0.07 | $67.8 |
| J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 760 | 116 | $0.96 | $728 |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 580 | 15 | $0.71 | $410 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 505 | 265 | $12.67 | $6,400 |
| 96413 Chemotherapy Administration | Office | 283 | 47 | $93.33 | $26K |
By year: 2022 $2.9M for 203,449 services; 2023 $2.6M for 145,455 services; 2024 $2.3M for 117,091 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 1,702 | 484 | $7.60 | $13K |
| 36415 Venipuncture Blood Collection | 1,445 | 466 | $8.64 | $12K |
| 85046 Blood Count | 90 | 60 | $5.40 | $486 |
| 81003 Clinical Chemistry | 33 | 26 | $2.20 | $72.6 |
Medicare prescription drug claims, 2024
In 2024, the drug Gail L Wright prescribed most often to Medicare patients was Anastrozole, with 147 prescriptions and refills. In total Gail L Wright wrote 1,046 Medicare prescriptions that cost $2.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 147 | 412 | 66 | $3,168 |
| Letrozole Generic | 68 | 141 | 19 | $1,231 |
| Gabapentin Generic | 59 | 92 | 14 | $889 |
| Tamoxifen Citrate Generic | 53 | 142 | 24 | $3,587 |
| Potassium Chloride Generic | 37 | 53 | 12 | $382 |
| Eliquis Apixaban | 32 | 40 | Under 11 | $22K |
| Prochlorperazine Maleate Generic | 28 | 28 | 13 | $649 |
| Tramadol Hcl Generic | 26 | 26 | 14 | $233 |
| Dexamethasone Generic | 24 | 26 | 16 | $498 |
| Xarelto Rivaroxaban | 24 | 46 | Under 11 | $25K |
| Oxycodone Hcl Generic | 23 | 23 | Under 11 | $563 |
| Ondansetron Odt Ondansetron | 22 | 22 | 11 | $1,610 |
| Fruzaqla Fruquintinib | 22 | 22 | Under 11 | $542K |
| Verzenio Abemaciclib | 21 | 21 | Under 11 | $296K |
| Lenalidomide Generic | 21 | 21 | Under 11 | $249K |
Brand drugs: 185 claims; generic drugs: 861 claims; opioid claims: 85.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Gail L Wright $2,767 ($2,767 in general payments such as food, travel and fees) from 40 companies. The largest payer was Novartis Pharmaceuticals Corporation with $278.
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation NVS | 17 | $278 |
| E.R. Squibb & Sons, L.L.C. BMY | 12 | $203 |
| Janssen Biotech, Inc. JNJ | 8 | $177 |
| AstraZeneca Pharmaceuticals LP AZN | 6 | $157 |
| Merck Sharp & Dohme LLC MRK | 6 | $141 |
| Abbvie Inc. ABBV | 5 | $134 |
| Pfizer Inc. PFE | 6 | $125 |
| TerSera Therapeutics LLC | 4 | $125 |
| Daiichi Sankyo Inc. 4568.T | 5 | $120 |
| Celgene Corporation BMY | 5 | $115 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.